PRTN3 and interstitial lung disease: In addition, RA disease features, such as longer disease duration (13), high disease activity (22) and serum autoantibodies, in particular rheumatoid factor (RF) and anti-citrullinated protein antibodies (ACPA) significantly increase the risk of developing ILD.